18287586. COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES simplified abstract (The Regents of the University of California)
Contents
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
Organization Name
The Regents of the University of California
Inventor(s)
Varghese John of Los Angeles CA (US)
Istvan Mody of Los Angeles CA (US)
Jesus J. Campagna of Playa Del Rey CA (US)
Barbara Jagodzinska of Redwood City CA (US)
Xiaofei Wei of Los Angeles CA (US)
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES - A simplified explanation of the abstract
This abstract first appeared for US patent application 18287586 titled 'COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
The present disclosure involves compounds that can increase γ-oscillations in the brain, with potential applications in treating neurodegenerative diseases or disorders.
- These compounds have the ability to enhance brain function by increasing γ-oscillations.
- The methods disclosed can be used to treat neurodegenerative diseases or disorders.
- By targeting γ-oscillations, these compounds offer a novel approach to addressing brain health issues.
- The innovation opens up new possibilities for therapeutic interventions in neurological conditions.
- This technology has the potential to improve cognitive function and overall brain health.
Potential Applications: - Treatment of neurodegenerative diseases such as Alzheimer's or Parkinson's - Cognitive enhancement in healthy individuals - Research in neuroscience and brain function studies
Problems Solved: - Lack of effective treatments for neurodegenerative diseases - Limited options for enhancing cognitive function - Challenges in understanding and modulating brain oscillations
Benefits: - Improved brain health and cognitive function - Potential for disease-modifying treatments in neurodegenerative conditions - Enhanced research capabilities in neuroscience
Commercial Applications: Title: Innovative Compounds for Enhancing Brain Function This technology could be utilized in pharmaceuticals for neurodegenerative disease treatments, cognitive enhancement supplements, and research tools for neuroscience studies.
Questions about Compounds for Increasing γ-Oscillations in the Brain: 1. How do these compounds specifically target γ-oscillations in the brain?
These compounds interact with neural circuits to modulate γ-oscillations, enhancing brain function.
2. What potential impact could this technology have on the field of neuroscience?
This technology could revolutionize our understanding of brain oscillations and their role in neurological disorders.
Original Abstract Submitted
The present disclosure relates to compounds which increase γ-oscillations in the brain. The disclosure further relates to methods of treating neurodegenerative diseases or disorders with the compounds disclosed herein.
- The Regents of the University of California
- Varghese John of Los Angeles CA (US)
- Istvan Mody of Los Angeles CA (US)
- Jesus J. Campagna of Playa Del Rey CA (US)
- Barbara Jagodzinska of Redwood City CA (US)
- Xiaofei Wei of Los Angeles CA (US)
- C07D401/14
- A61K31/4155
- A61K31/454
- A61K31/4709
- A61K31/4725
- A61K31/55
- A61P25/28
- C07D401/04
- C07D403/04
- C07D405/14
- CPC C07D401/14